All Stories

  1. Multiomic profiling of medulloblastoma reveals subtype-specific targetable alterations at the proteome and N-glycan level
  2. Translocator protein (18kDa) TSPO: a new diagnostic or therapeutic target for stress-related disorders?
  3. Long-term diazepam treatment enhances microglial spine engulfment and impairs cognitive performance via the mitochondrial 18 kDa translocator protein (TSPO)
  4. Anaplastic pleomorphic xanthoastrocytoma with epithelioid morphology misdiagnosed and treated as melanoma
  5. Mutations within FGFR1 are associated with superior outcome in a series of 83 diffuse midline gliomas with H3F3A K27M mutations
  6. Extent and prognostic value of MGMT promotor methylation in glioma WHO grade II
  7. Molecular characterization of histopathological ependymoma variants
  8. Early defects in translation elongation factor 1α levels at excitatory synapses in α-synucleinopathy
  9. Tcf4 regulates dendritic spine density and morphology in the adult brain
  10. K27M midline gliomas display malignant progression by imaging and histology
  11. High plasticity of axonal pathology in Alzheimer’s disease mouse models
  12. Beta-Site Amyloid Precursor Protein Cleaving Enzyme 1 Inhibition Impairs Synaptic Plasticity via Seizure Protein 6
  13. Dendritic Spine Pathology in Neurodegenerative Diseases
  14. Distinct Histomorphology in Molecular Subgroups of Glioblastomas in Young Patients
  15. Neuroinflammation impairs adaptive structural plasticity of dendritic spines in a preclinical model of Alzheimer’s disease
  16. δ Subunit-containing GABAA receptors are preferred targets for the centrally acting analgesic flupirtine
  17. Miliary pattern of brain metastases – a case report of a hyperacute onset in a patient with malignant melanoma documented by magnetic resonance imaging
  18. Analyzing dendritic spine pathology in Alzheimer’s disease: problems and opportunities
  19. Intraneuronal APP and extracellular Aβ independently cause dendritic spine pathology in transgenic mouse models of Alzheimer’s disease
  20. Immunotherapy alleviates amyloid-associated synaptic pathology in an Alzheimer's disease mouse model
  21. Loss of neuronal GSK3β reduces dendritic spine stability and attenuates excitatory synaptic transmission via β-catenin
  22. Pathological α-synuclein impairs adult-born granule cell development and functional integration in the olfactory bulb
  23. In vivo imaging reveals sigmoidal growth kinetic of β-amyloid plaques
  24. Constitutive activation of β-Catenin in neural progenitors results in disrupted proliferation and migration of neurons within the central nervous system
  25. Impaired plasticity of cortical dendritic spines in P301S tau transgenic mice
  26. Arc illuminates Alzheimer's pathophysiology
  27. Amyloid plaque formation precedes dendritic spine loss
  28. Concomitant facilitation of GABAA receptors and KV7 channels by the non‐opioid analgesic flupirtine
  29. 4D in in vivo 2-photon laser scanning fluorescence microscopy with sample motion in 6 degrees of freedom
  30. In vivo multiphoton imaging reveals gradual growth of newborn amyloid plaques over weeks
  31. Computational processing of optical measurements of neuronal and synaptic activity in networks
  32. A genetically encoded reporter of synaptic activity in vivo
  33. Physical and Functional Interaction between the Dopamine Transporter and the Synaptic Vesicle Protein Synaptogyrin-3
  34. Opposite effects of presynaptic 5-HT3receptor activation on spontaneous and action potential-evoked GABA release at hippocampal synapses
  35. The brain-specific double-stranded RNA-binding protein Staufen2 is required for dendritic spine morphogenesis
  36. The Ubiquitin-Specific Protease Usp4 Regulates the Cell Surface Level of the A2a Receptor
  37. Serotonin-transporter mediated efflux: A pharmacological analysis of amphetamines and non-amphetamines
  38. Autoinhibition of transmitter release from PC12 cells and sympathetic neurons through a P2Y12 receptor-mediated inhibition of voltage-gated Ca2+ channels
  39. Two Discontinuous Segments in the Carboxyl Terminus Are Required for Membrane Targeting of the Rat  -Aminobutyric Acid Transporter-1 (GAT1)